Financiële vergelijkingen Lonza Group AG
Aandelen
LONN
CH0013841017
Biotechnologie & Medisch Onderzoek
|
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 568,20 CHF | +0,42% |
|
+5,64% | +5,21% |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Omzet (Y-1) | Nettomarge (Y-1) | Ebit-marge (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | |
|---|---|---|---|---|---|---|---|
 | 7,25 mld. | 9,67% | 17,9% | 6,77% | 3,48% | 1.5x | |
| 15,4 mld. | 8,91% | 20,12% | 33,53% | 5,12% | 3.33x | |
| 3,81 mld. | -16,92% | -14,91% | -18,77% | -11% | 4.06x | |
| 2,41 mld. | 11,88% | 13,83% | 2,46% | 2,14% | 1.28x | |
| 2,11 mld. | 19,17% | 21,38% | 58,42% | 21,52% | -1.39x | |
| 7,2 mld. | 5,84% | 14,63% | 7,8% | 3,73% | 1.93x | |
| 8,28 mld. | 9,56% | 19,29% | 12,39% | 6,87% | 1.66x | |
| 705 mln. | -64,4% | -67,38% | -93,12% | -15,15% | 2.26x | |
| 376 mln. | -103,97% | -76,66% | - | -37,71% | -1.14x | |
| 693 mln. | -107,63% | -20,47% | - | -25,37% | 0.13x | |
| 4,05 mld. | 0,25% | 19,9% | 15,1% | 6,78% | 2.05x | |
| 1,22 mld. | 6,02% | 31,45% | 15,37% | 11,65% | 0.43x | |
| 1,98 mld. | 4,23% | 28,66% | 13,31% | 8,32% | 0.34x | |
| 12,94 mln. | -1.409,6% | -1.383,2% | -148,95% | - | 0.4x | |
| 509 mln. | -13,19% | -41,67% | -31,26% | -21,6% | -0.14x | |
| 8,55 mln. | -2.137,48% | -2.340,29% | -70,98% | -64,03% | 1.96x | |
| 1,68 mld. | 14,61% | 17,14% | 13,7% | 7,12% | 1.33x | |
| 905 mln. | 6,14% | 7,92% | 1,94% | 1,39% | 0.27x | |
| Gemiddelde | 3,26 mld. | -208,72% | -207,35% | -11,39% | -5,69% | 1,13x | |
| Gewogen gemiddelde per kap. | 5,05 mld. | -100,79% | -94,7% | -1,73% | -2,51% | 1,61x |
- Beurs
- Aandelen
- Koers LONN
- Sector Lonza Group AG
- Financiële vergelijkingen
Kies jouw editie
Alle financiële informatie op nationaal niveau
